Market research
HAE.F HAEMATO AG
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 53M
- P/E ratio
- 17.46
- Analyst target
- 7.75
- Dividend yield
- 9.8%
- Beta
- 1.37
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- DE0006190705
- Market cap
- 53M
- P/E ratio
- 17.46
- Analyst target
- 7.75
- Dividend yield
- 9.8%
- Beta
- 1.37
About
About HAEMATO AG
HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European import medicinal products; and manufactures and distributes its own generic medicinal products. It provides pharmaceuticals in the areas of oncology, HIV/AIDS, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic treatments. The company also develops and commercializes pharmaceutical, medicinal, and medical engineering products for aesthetic surgery and cosmetic dermatology. It serves wholesalers and pharmacies, as well as doctors and hospitals. The company was founded in 1993 and is headquartered in Schönefeld, Germany. HAEMATO AG is a subsidiary of MPH Health Care AG.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the HAE.F discussion.
5 years, 5 months ago
HAEMATO AG is currently in a long term downtrend where the price is trading 18.4% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.2.
Based on the above factors, HAEMATO AG gets an overall score of 1/5.